Inhibition of store-operated Ca2+ entry suppresses EGF-induced migration and eliminates extravasation from vasculature in nasopharyngeal carcinoma cell

Cancer Letters

Volumn 336, Issue 2, 2013, Pages 390-397

  Zhang, Jinyan ^a   Wei, Jiazhang ^a   Kanada, Masamitsu ^a,c   Yan, Libo ^a   Zhang, Zhe ^b   Watanabe, Hiroshi ^a   Terakawa, Susumu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Metastasis; Migration; Nasopharyngeal carcinoma; Store operated Ca2+ entry

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; EPIDERMAL GROWTH FACTOR; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER CELL; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DISEASE MODEL; DRUG TARGETING; EXTRACELLULAR MATRIX; EXTRAVASATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; ZEBRA FISH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CELL LINE, TUMOR; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; HUMANS; ION TRANSPORT; MEMBRANE PROTEINS; NASOPHARYNGEAL NEOPLASMS; SIGNAL TRANSDUCTION; ZEBRAFISH;

DANIO RERIO;

EID: 84879781744     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.03.026     Document Type: Article

References (47)

1. Vokes E.E., Liebowitz D.N., Weichselbaum R.R. Nasopharyngeal carcinoma. Lancet 1997, 350:1087-1091.
2. Lee N., Xia P., Quivey J.M., Sultanem K., Poon I., Akazawa C., Akazawa P., Weinberg V., Fu K.K. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int. J. Radiat. Oncol. Biol. Phys. 2002, 53:12-22.
3. Kam M.K., Teo P.M., Chau R.M., Cheung K.Y., Choi P.H., Kwan W.H., Leung S.F., Zee B., Chan A.T. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int. J. Radiat. Oncol. Biol. Phys. 2004, 60:1440-1450.
4. Baujat B., Audry H., Bourhis J., Chan A.T., Onat H., Chua D.T., Kwong D.L., Al-Sarraf M., Chi K.H., Hareyama M., Leung S.F., Thephamongkhol K., Pignon J.P. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64:47-56.
5. Yi J.L., Gao L., Huang X.D., Li S.Y., Luo J.W., Cai W.M., Xiao J.P., Xu G.Z. Nasopharyngeal carcinoma treated by radical radiotherapy alone: 10-year experience of a single institution. Int. J. Radiat. Oncol. Biol. Phys. 2006, 65:161-168.
6. Ma J., Liu L., Tang L., Zong J., Lin A., Lu T., Cui N., Cui C., Li L. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories. Clin. Cancer Res. 2007, 13:1445-1452.
7. Tang L., Mao Y., Liu L., Liang S., Chen Y., Sun Y., Liao X., Lin A., Liu M., Li L., Ma J. The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging. Cancer 2009, 115:680-688.
8. Hui E.P., Leung S.F., Au J.S., Zee B., Tung S., Chua D., Sze W.M., Law C.K., Leung T.W., Chan A.T. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Cancer 2004, 101:300-306.
9. Mao Y.P., Xie F.Y., Liu L.Z., Sun Y., Li L., Tang L.L., Liao X.B., Xu H.Y., Chen L., Lai S.Z., Lin A.H., Liu M.Z., Ma J. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 2009, 73:1326-1334.
10. Ma B.B., Chan A.T. Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma. Expert Rev. Anticancer Ther. 2006, 6:383-394.
11. Mareel M., Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 2003, 83:337-376.
12. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 2006, 12:895-904.
13. Tsao S.W., Tramoutanis G., Dawson C.W., Lo A.K., Huang D.P. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin. Cancer Biol. 2002, 12:473-487.
14. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 2002, 12:431-441.
15. Dawson C.W., Port R.J., Young L.S. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin. Cancer Biol. 2012, 22:144-153.
16. Clapham D.E. Calcium signaling. Cell 2007, 131:1047-1058.
17. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
18. 2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 2008, 8:361-375.
19. Marks P.W., Maxfield F.R. Transient increases in cytosolic free calcium appear to be required for the migration of adherent human neutrophils. J. Cell Biol. 1990, 110:43-52.
20. Komuro H., Rakic P. Modulation of neuronal migration by NMDA receptors. Science 1993, 260:95-97.
21. Lee J., Ishihara A., Oxford G., Johnson B., Jacobson K. Regulation of cell movement is mediated by stretch-activated calcium channels. Nature 1999, 400:382-386.
22. 2+ channels sets the polarity of nerve growth-cone turning. Nature 2003, 423:990-995.
23. 2+ channels controls the trailing tail contraction in growth factor-induced fibroblast cell migration. J. Biol. Chem. 2005, 280:27130-27137.
24. Potier M., Gonzalez J.C., Motiani R.K., Abdullaev I.F., Bisaillon J.M., Singer H.A., Trebak M. Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. Faseb. J. 2009, 23:2425-2437.
25. Yang S., Zhang J.J., Huang X.Y. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 2009, 15:124-134.
26. Chen Y.F., Chiu W.T., Chen Y.T., Lin P.Y., Huang H.J., Chou C.Y., Chang H.C., Tang M.J., Shen M.R. Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis. Proc. Natl. Acad. Sci. USA 2011, 108:15225-15230.
27. 2+ entry in endothelial cells by myosin light-chain kinase inhibitor. Biochem. Biophys. Res. Commun. 1996, 225:777-784.
28. Bird G.S., DeHaven W.I., Smyth J.T., Putney J.W. Methods for studying store-operated calcium entry. Methods 2008, 46:204-212.
29. Stoletov K., Kato H., Zardouzian E., Kelber J., Yang J., Shattil S., Klemke R. Visualizing extravasation dynamics of metastatic tumor cells. J. Cell Sci. 2010, 123:2332-2341.
30. 2+ influx. J. Cell Sci. 1997, 110(Pt 22):2845-2853.
31. Xu H.T., Yuan X.B., Guan C.B., Duan S., Wu C.P., Feng L. Calcium signaling in chemorepellant Slit2-dependent regulation of neuronal migration. Proc. Natl. Acad. Sci. USA 2004, 101:4296-4301.
32. Tam T., Mathews E., Snutch T.P., Schafer W.R. Voltage-gated calcium channels direct neuronal migration in Caenorhabditis elegans. Dev. Biol. 2000, 226:104-117.
33. Bisaillon J.M., Motiani R.K., Gonzalez-Cobos J.C., Potier M., Halligan K.E., Alzawahra W.F., Barroso M., Singer H.A., Jourd'heuil D., Trebak M. Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration. Am. J. Physiol. Cell Physiol. 2010, 298:C993-1005.
34. Montana V., Sontheimer H. Bradykinin promotes the chemotactic invasion of primary brain tumors. J. Neurosci. 2011, 31:4858-4867.
35. Chen J.P., Luan Y., You C.X., Chen X.H., Luo R.C., Li R. TRPM7 regulates the migration of human nasopharyngeal carcinoma cell by mediating Ca(2+) influx. Cell Calcium 2010, 47:425-432.
36. Rudolph M.I., Boza Y., Yefi R., Luza S., Andrews E., Penissi A., Garrido P., Rojas I.G. The influence of mast cell mediators on migration of SW756 cervical carcinoma cells. J. Pharmacol. Sci. 2008, 106:208-218.
37. Miller W.E., Earp H.S., Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol. 1995, 69:4390-4398.
38. Kung C.P., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3. J. Virol. 2008, 82:5486-5493.
39. Allen M.D., Young L.S., Dawson C.W. The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. J. Virol. 2005, 79:1789-1802.
40. Nguyen D.X., Bos P.D., Massague J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 2009, 9:274-284.
41. Flusberg B.A., Cocker E.D., Piyawattanametha W., Jung J.C., Cheung E.L., Schnitzer M.J. Fiber-optic fluorescence imaging. Nat. Methods 2005, 2:941-950.
42. Beerling E., Ritsma L., Vrisekoop N., Derksen P.W., van Rheenen J. Intravital microscopy: new insights into metastasis of tumors. J. Cell Sci. 2011, 124:299-310.
43. Stoletov K., Montel V., Lester R.D., Gonias S.L., Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc. Natl. Acad. Sci. USA 2007, 104:17406-17411.
44. Berghmans S., Murphey R.D., Wienholds E., Neuberg D., Kutok J.L., Fletcher C.D., Morris J.P., Liu T.X., Schulte-Merker S., Kanki J.P., Plasterk R., Zon L.I., Look A.T. Tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc. Natl. Acad. Sci. USA 2005, 102:407-412.
45. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 2005, 4:35-44.
46. Stoletov K., Klemke R. Catch of the day: zebrafish as a human cancer model. Oncogene 2008, 27:4509-4520.
47. Yang N., Tang Y., Wang F., Zhang H., Xu D., Shen Y., Sun S., Yang G. Blockade of store-operated Ca(2+) entry inhibits hepatocarcinoma cell migration and invasion by regulating focal adhesion turnover. Cancer Lett. 2013, 330:163-169.